Optimizing cognitive enhancement through dopamine transporter modulation

) would enhance cognitive function more effectively. To test this, we evaluated a series of R-modafinil analogs using in vitro equilibrium and non-equilibrium measurements, in vivo fast-scan cyclic voltammetry, and highly translational cognitive assays in both healthy and scopolamine-treated rats modelling cognitive impairment. Our findings show that prolonging DAT occupancy improves dopamine signalling and leads to more robust enhancements in cognitive flexibility. Compounds with longer DAT resident time-such as S-MK-26 and (S,S)-CE-158-produced the strongest cognitive effects. These results highlight the importance of DAT binding kinetics in shaping the behavioural actions of psychostimulants and support the development of safer and more effective dopamine-based cognitive enhancers.

Authors

Institutions

Publication Details

Journal
Neuropharmacology
Published
2026-04-12
DOI
https://doi.org/10.1016/j.neuropharm.2026.110969
Primary Topic
Neurotransmitter Receptor Influence on Behavior
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing cognitive enhancement through dopamine transporter modulation

Michael Kirchhofer, Michele Santoni, Simone B. Sartori, Nicolas Singewald et al.
Neuropharmacology
Neurotransmitter Receptor Influence on Behavior
article

Optimizing cognitive enhancement through dopamine transporter modulation

Michael Kirchhofer, Michele Santoni, Simone B. Sartori, Nicolas Singewald, Karl Ebner, Claudia Sagheddu, Jana Lubec, Tamara Stojanovic, Iva Spreitzer, Harald H. Sitte, Gert Lübec, Predrag Kalaba, Marco Niello, Judith Wackerlig-Damle, Marco Pistis, Markus Spreitzer, Ahmed M. Hussein, Anita Cybulska-Klosowicz
article en

Abstract

) would enhance cognitive function more effectively. To test this, we evaluated a series of R-modafinil analogs using in vitro equilibrium and non-equilibrium measurements, in vivo fast-scan cyclic voltammetry, and highly translational cognitive assays in both healthy and scopolamine-treated rats modelling cognitive impairment. Our findings show that prolonging DAT occupancy improves dopamine signalling and leads to more robust enhancements in cognitive flexibility. Compounds with longer DAT resident time-such as S-MK-26 and (S,S)-CE-158-produced the strongest cognitive effects. These results highlight the importance of DAT binding kinetics in shaping the behavioural actions of psychostimulants and support the development of safer and more effective dopamine-based cognitive enhancers.

NeuropharmacologyVol. 294
University of Vienna (AT), University of Cagliari (IT), Universität Innsbruck (AT), Paracelsus Medical University (AT), Italian Institute of Technology (IT), Medical University of Vienna (AT), BOKU University (AT), Polish Academy of Sciences (PL)
Austrian Science Fund, Ministero della Salute, Regione Autonoma della Sardegna, Ministero dell'Università e della Ricerca, Ministero dell'Istruzione e del Merito
Openalex Percentile: Top 29%
Neurotransmitter Receptor Influence on Behavior
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.